2.83
price up icon0.05%   0.03
 
loading
Schlusskurs vom Vortag:
$2.80
Offen:
$2.78
24-Stunden-Volumen:
2,043
Relative Volume:
0.05
Marktkapitalisierung:
$18.46M
Einnahmen:
$105.38M
Nettoeinkommen (Verlust:
$17.78M
KGV:
-0.6112
EPS:
-4.63
Netto-Cashflow:
$-50.48M
1W Leistung:
-6.93%
1M Leistung:
+2.24%
6M Leistung:
-10.21%
1J Leistung:
-53.15%
1-Tages-Spanne:
Value
$2.77
$2.87
1-Wochen-Bereich:
Value
$2.76
$3.01
52-Wochen-Spanne:
Value
$2.61
$6.9099

Mei Pharma Inc Stock (MEIP) Company Profile

Name
Firmenname
Mei Pharma Inc
Name
Telefon
858-369-7100
Name
Adresse
11455 EL CAMINO REAL, SAN DIEGO, CA
Name
Mitarbeiter
28
Name
Twitter
@MEI_Pharma
Name
Nächster Verdiensttermin
2024-11-07
Name
Neueste SEC-Einreichungen
Name
MEIP's Discussions on Twitter

Vergleichen Sie MEIP mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
MEIP 2.835 18.46M 105.38M 17.78M -50.48M -4.63
VRTX 449.14 115.43B 10.63B -479.80M -1.35B 13.33
REGN 749.22 82.04B 13.85B 4.65B 3.32B 35.06
ARGX 587.39 35.30B 1.86B -40.29M -1.28B -4.16
ALNY 248.00 32.04B 2.09B -332.26M 16.06M -4.14
BNTX 107.00 24.89B 3.30B -501.07M 1.03B 11.54

Mei Pharma Inc Stock (MEIP) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2022-03-25 Herabstufung Jefferies Buy → Hold
2022-03-25 Herabstufung Stifel Buy → Hold
2022-03-25 Herabstufung Wells Fargo Overweight → Equal Weight
2022-02-03 Eingeleitet Jefferies Buy
2020-09-22 Eingeleitet Alliance Global Partners Buy
2020-05-29 Eingeleitet SunTrust Buy
2018-12-20 Eingeleitet H.C. Wainwright Buy
2018-07-27 Hochstufung Stifel Hold → Buy
2018-07-13 Eingeleitet SunTrust Buy
2016-04-18 Bestätigt Wedbush Neutral
2015-03-23 Herabstufung ROTH Capital Buy → Neutral
2014-12-18 Bestätigt ROTH Capital Buy
2014-10-16 Bestätigt ROTH Capital Buy
2014-07-08 Fortgesetzt Brean Capital Buy
2013-10-22 Bestätigt Stifel Buy
2013-04-15 Eingeleitet Stifel Buy
Alle ansehen

Mei Pharma Inc Aktie (MEIP) Neueste Nachrichten

pulisher
Nov 13, 2024

MEI Pharma Reports Strategic Shift Amid Financial Losses - TipRanks

Nov 13, 2024
pulisher
Nov 12, 2024

MEI Pharma, Inc. Reports Earnings Results for the First Quarter Ended September 30, 2024 - Marketscreener.com

Nov 12, 2024
pulisher
Nov 12, 2024

MEI Pharma reports Q1 EPS ($1.20) vs. $8.46 last year - TipRanks

Nov 12, 2024
pulisher
Nov 07, 2024

Acute Myeloid Leukemia (AML) Treatment Market in APAC to Grow by USD 305.8 Million from 2024-2028, Driven by High Incidence and AI-Driven Market TransformationTechnavio - Kilgore News Herald

Nov 07, 2024
pulisher
Oct 31, 2024

Layoff Tracker: Compass Pathways to Lay Off 30% of Employees - BioSpace

Oct 31, 2024
pulisher
Oct 28, 2024

Pre-market Movers: EVOK, HCTI, GLUE, MNPR... - RTTNews

Oct 28, 2024
pulisher
Oct 27, 2024

Data Readouts At EHA Congress 2021 (APTO, XFOR, GBT, CRIS…) - RTTNews

Oct 27, 2024
pulisher
Oct 25, 2024

Stocks to Watch: MEI Pharma, Hawaiian Electric Industries - MarketWatch

Oct 25, 2024
pulisher
Oct 25, 2024

MEI Shares Rise After Entering Asset Purchase Agreement Valued at Up to $62 Million - MarketWatch

Oct 25, 2024
pulisher
Oct 25, 2024

MEI Pharma postpones special meeting to vote on Infinity deal until July 23 - MSN

Oct 25, 2024
pulisher
Oct 24, 2024

Aardvark Therapeutics, Inc. agreed to acquire rights, title and interest in and to certain assets related to ME-344 from MEI Pharma, Inc. for $62.5 million. - Marketscreener.com

Oct 24, 2024
pulisher
Oct 24, 2024

MEIP (MEI Pharma) Free Cash Flow per Share : $-7.57 (TTM As of Jun. 2024) - GuruFocus.com

Oct 24, 2024
pulisher
Oct 22, 2024

Post Polycythemia Vera Myelofibrosis Market: Holistic - openPR

Oct 22, 2024
pulisher
Oct 14, 2024

Ampio Pharmaceuticals (NYSE:AMPE) Coverage Initiated by Analysts at StockNews.com - Defense World

Oct 14, 2024
pulisher
Oct 09, 2024

MEI Pharma stock hits 52-week low at $2.72 amid market challenges - Investing.com India

Oct 09, 2024
pulisher
Oct 08, 2024

MEI Pharma stock hits 52-week low at $2.72 amid market challenges By Investing.com - Investing.com South Africa

Oct 08, 2024
pulisher
Oct 01, 2024

Acute Myeloid Leukemia Market Trends, Key Drivers, Opportunities, Leading Players And Forecast To 2033 - WhaTech

Oct 01, 2024
pulisher
Sep 25, 2024

Histone Deacetylase 2 Industry Forecast (2024-2034) Under Inflation - Apiculture Market: Report ...

Sep 25, 2024
pulisher
Sep 23, 2024

Myelodysplastic Syndrome Drugs Market Research Explores Size, Market Competitive Landscape, Business Growth... - WhaTech

Sep 23, 2024
pulisher
Sep 22, 2024

Chronic Lymphocytic Leukemia Treatment Market Advancements Highlighted by Comprehensive Analysis, Advanceme... - WhaTech

Sep 22, 2024
pulisher
Sep 20, 2024

Follicular Lymphoma Treatment Market Insights Discussed Regarding Size, Trends, and Overview Report 2024-2033 - WhaTech

Sep 20, 2024
pulisher
Sep 20, 2024

MEI Pharma reviews strategic options amid fiscal changes - Investing.com India

Sep 20, 2024
pulisher
Sep 19, 2024

MEI Pharma confirms continuation of evaluation of strategic alternatives - TipRanks

Sep 19, 2024
pulisher
Sep 19, 2024

MEI Pharma Reports Fiscal Year End 2024 Cash Position - The Bakersfield Californian

Sep 19, 2024
pulisher
Sep 16, 2024

Expanding the Bispecific Antibody Market from CAR-Ts to Drive Follicular Lymphoma's Future | DelveInsight - PR Newswire UK

Sep 16, 2024
pulisher
Sep 15, 2024

LPL Financial (NASDAQ:LPLA) Research Coverage Started at Wells Fargo & Company - Defense World

Sep 15, 2024
pulisher
Sep 15, 2024

Los Angeles Capital Management LLC Reduces Stake in Martin Marietta Materials, Inc. (NYSE:MLM) - Defense World

Sep 15, 2024
pulisher
Sep 05, 2024

Mei Pharma announces exclusive license agreement with Presage Biosciences for voruciclib - Reuters.com

Sep 05, 2024
pulisher
Sep 02, 2024

Histone Deacetylase Inhibitors Report 2024, Industry Analysis And Overview By 2033 - WhaTech

Sep 02, 2024
pulisher
Aug 23, 2024

Post-Polycythemia Vera Myelofibrosis (PPV-MF) Industry - openPR

Aug 23, 2024
pulisher
Aug 17, 2024

MEIP (MEI Pharma) Dividends per Share : $0.00 (TTM As of Mar. 2024) - GuruFocus.com

Aug 17, 2024
pulisher
Aug 16, 2024

Rx Rundown: Vantive, Gilead Sciences, Halda Therapeutics and more - MM+M Online

Aug 16, 2024
pulisher
Aug 12, 2024

MEI Pharma Engages Oppenheimer & Co. Inc. to Assist in Evaluating Strategic Alternatives - StockTitan

Aug 12, 2024
pulisher
Aug 11, 2024

StockNews.com Initiates Coverage on MEI Pharma (NASDAQ:MEIP) - Defense World

Aug 11, 2024
pulisher
Aug 07, 2024

GreenWood Investors First Half 2024 Letter - Seeking Alpha

Aug 07, 2024
pulisher
Aug 05, 2024

MEI Pharma (MEIP) – Research Analysts’ Recent Ratings Updates - Defense World

Aug 05, 2024
pulisher
Aug 05, 2024

Game-Changing BCL-2 Inhibitors Set to Revolutionize Cancer Treatment Market | DelveInsight - GlobeNewswire

Aug 05, 2024
pulisher
Aug 03, 2024

MEI Pharma announces executive departures and strategic shifts - Investing.com

Aug 03, 2024
pulisher
Aug 02, 2024

MEI Pharma announces executive departures and strategic shifts By Investing.com - Investing.com Canada

Aug 02, 2024
pulisher
Aug 02, 2024

MEI Pharma Explores Strategic Shifts, Leadership Changes - TipRanks

Aug 02, 2024
pulisher
Aug 01, 2024

Non-Hodgkin's Lymphoma Therapeutics Market to Reach USD 18.6 Billion by 2034: Fuelled by New Drugs and Targeted Therapies | Latest Report by TMR - PR Newswire

Aug 01, 2024
pulisher
Jul 30, 2024

MEI Pharma Explores Strategic Options, Halts Drug Development - TipRanks

Jul 30, 2024
pulisher
Jul 27, 2024

Acadian Asset Management LLC Sells 13,658 Shares of MEI Pharma, Inc. (NASDAQ:MEIP) - Defense World

Jul 27, 2024
pulisher
Jul 26, 2024

Biopharma Layoff Tracker 2024: Anokion, GlycoMimetics, Relay and More Cut Staff - BioSpace

Jul 26, 2024
pulisher
Jul 26, 2024

MEI Pharma (NASDAQ:MEIP) Receives New Coverage from Analysts at StockNews.com - Defense World

Jul 26, 2024
pulisher
Jul 26, 2024

StockNews.com Initiates Coverage on Perficient (NASDAQ:PRFT) - Defense World

Jul 26, 2024
pulisher
Jul 24, 2024

MEI Pharma (NASDAQ:MEIP) Downgraded by Brookline Capital Management - Defense World

Jul 24, 2024
pulisher
Jul 24, 2024

State Board of Administration of Florida Retirement System Increases Stake in Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN) - Defense World

Jul 24, 2024
pulisher
Jul 24, 2024

Blair William & Co. IL Takes Position in BRC Inc. (NYSE:BRCC) - Defense World

Jul 24, 2024
pulisher
Jul 24, 2024

Avantax Advisory Services Inc. Buys Shares of 8,840 Dimensional World ex U.S. Core Equity 2 ETF (NYSEARCA:DFAX) - Defense World

Jul 24, 2024
pulisher
Jul 23, 2024

MEI Pharma (NASDAQ:MEIP) Downgraded by Laidlaw - Defense World

Jul 23, 2024

Finanzdaten der Mei Pharma Inc-Aktie (MEIP)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading
$18.98
price up icon 1.80%
$70.68
price down icon 0.42%
$38.38
price up icon 3.49%
$369.83
price up icon 1.48%
$196.58
price up icon 0.88%
$102.64
price up icon 0.27%
Kapitalisierung:     |  Volumen (24h):